Literature DB >> 20045285

Variability of polymyxin B major components in commercial formulations.

Jie He, Kimberly R Ledesma, Wai-Ying Lam, Deborah A Figueroa, Tze-Peng Lim, Diana S-L Chow, Vincent H Tam.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 20045285     DOI： 10.1016/j.ijantimicag.2009.11.005

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  15 in total

1.  In vitro potency of various polymyxin B components.

Authors:  Vincent H Tam; Henry Cao; Kimberly R Ledesma; Ming Hu
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

2.  Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report.

Authors:  Andrea L H Kwa; Kamilia Abdelraouf; Jenny G H Low; Vincent H Tam
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 3.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model.

Authors:  Jie He; Kamilia Abdelraouf; Kimberly R Ledesma; Diana S-L Chow; Vincent H Tam
Journal:  Int J Antimicrob Agents       Date:  2013-08-22       Impact factor: 5.283

5.  High performance liquid chromatography-mass spectrometry assay for polymyxin B1 and B2 in human plasma.

Authors:  Tiffany A Thomas; Emily C Broun; Kirsten M Abildskov; Christine J Kubin; Jennifer Horan; Michael T Yin; Serge Cremers
Journal:  Ther Drug Monit       Date:  2012-08       Impact factor: 3.681

6.  Uptake of polymyxin B into renal cells.

Authors:  Kamilia Abdelraouf; Kai-Tai Chang; Taijun Yin; Ming Hu; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

7.  Microbiological Assessment of Polymyxin B Components Tested Alone and in Combination.

Authors:  Zahra Kassamali; Randall A Prince; Larry H Danziger; John C Rotschafer; Paul R Rhomberg; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

8.  Pharmacokinetics and renal disposition of polymyxin B in an animal model.

Authors:  Kamilia Abdelraouf; Jie He; Kimberly R Ledesma; Ming Hu; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 9.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

10.  Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria.

Authors:  Kade D Roberts; Mohammad A K Azad; Jiping Wang; Andrew S Horne; Philip E Thompson; Roger L Nation; Tony Velkov; Jian Li
Journal:  ACS Infect Dis       Date:  2015-09-04       Impact factor: 5.084
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.